Company Overview and News

Stop missing out on important events!

Fintel provides real time notifications of important company events such as major investments (13D/G filings), insider trades (SEC form 4), and important SEC filings. Sign up and create your company alerts for free.

Headline News

Lexaria Announces Exercises of Existing Warrants

2018-02-02 accesswire
KELOWNA, BRITISH COLUMBIA / ACCESSWIRE / February 2, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces warrant transactions. (5-0)

Marijuana Stocks And Australia: Is The Next Boom Down Under?

2018-01-31 seekingalpha
North American marijuana legalization has spurred global awareness for positive uses for the drug & for sales of it. (35-1)

Lexaria Enters Licensing Agreement with Canadian Cannabis Chocolate Manufacturer

2018-01-25 accesswire
KELOWNA, BC / ACCESSWIRE / January 25, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CNSX: LXX) (the "Company" or "Lexaria") a drug delivery platform innovator, announces it has entered a definitive technology licensing agreement (the "Agreement") with Cannfections Group Inc. whereby Lexaria is providing its patented DehydraTECH™ technology to empower next-generation performance in cannabis infused chocolates and candies to be developed and sold in Canada and internationally. (5-0)

Lexaria Announces Exercises of Existing Warrants

2018-01-17 accesswire
KELOWNA, BC / ACCESSWIRE / January 17, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces various option and warrant transactions. (5-0)

2017 Wrap-Up by Lexaria's CEO

2018-01-08 accesswire
KELOWNA, BC / ACCESSWIRE / January 8, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the ''Company'' or ''Lexaria'') announces it's been quite an amazing year for Lexaria stakeholders - the busiest and most productive we've had. I've welcomed so many new shareholders and Lexaria fans in 2017 and I want to ensure both our new followers as well as our long-term supporters remember just how much we've achieved in the past year. (5-1)

Lexaria Bioscience Files S4 Prospectus to Re-Domicile To Canada

2018-01-08 accesswire
KELOWNA, BC / ACCESSWIRE / January 8, 2018 / Lexaria Bioscience Corp. (OTCQX: LXRP) (CSE: LXX) (the ''Company'' or ''Lexaria'') announces that, on January 5, 2018, it filed a registration statement and shareholder information circular on Form S-4 with the US Securities and Exchange Commission (the ''SEC'') pursuant to which Lexaria will seek shareholder approval to change its corporate domicile from the State of Nevada to the Province of British Columbia, Canada, home of Lexaria's operations and management. (5-0)

Lexaria Upgrades to the OTCQX Market

2018-01-04 accesswire
KELOWNA, BC / ACCESSWIRE / January 4, 2018 / Lexaria Bioscience Corp. (formerly OTCQB: LXRP) (CSE: LXX) (the ''Company'' or ''Lexaria''), a drug delivery platform innovator, announces it has qualified and is now trading on the OTCQX Best Market (OTCQX: LXRP), operated by OTC Markets Group. (5-1)

Lexaria Announces Exercises of Existing Warrants

2017-12-23 accesswire
KELOWNA, BC / ACCESSWIRE / December 22, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the “Company” or “Lexaria”) announces various option and warrant transactions. (5-0)

Lexaria Bioscience Announces New Research Including Cannabinoid Topical Creams and Nicotine Edibles

2017-12-15 accesswire
KELOWNA, BC / ACCESSWIRE / December 15, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces a new topical skin cream research and development ("R&D") program; R&D into nicotine edibles; and updates existing R&D programs. (5-0)

Lexaria Bioscience Receives U.S. Patent Award for its DehydraTECH(TM) Delivery of THC, NSAIDs, Nicotine and Vitamins

2017-12-13 accesswire
KELOWNA, BC / ACCESSWIRE / December 13, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria"), a drug delivery platform innovator, announces the United States Patent and Trademark Office ("USPTO") has granted patent number 9,839,612 B2 for the use of DehydraTECH™ technology as a delivery platform for a wide variety of Active Pharmaceutical Ingredients ("APIs") including all cannabinoids including THC, fat soluble vitamins, non-steroidal anti-inflammatory pain medications ("NSAIDs"), and nicotine. (5-0)

Lexaria Announces Option and Warrant Transactions

2017-12-01 accesswire
KELOWNA, BC / ACCESSWIRE / December 1, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces various stock, option and warrant transactions. (5-1)

Lexaria Bioscience Announces Upcoming Investment Event and Warrant Exercise

2017-11-27 accesswire
KELOWNA, BC / ACCESSWIRE / November 27, 2017 / Lexaria Bioscience Corp. (OTCQB: LXRP) (CSE: LXX) (the "Company" or "Lexaria") announces it is attending and delivering a presentation at the upcoming 10th annual LD Micro Main Event on December 5-7, located in Los Angeles. More information on the event can be found here. (20-0)

NeutriSci Announces Pending Approval From Japanese Government for Distribution of CBD Products Through Naturally Splendid

2017-11-06 marketwired
VANCOUVER, BC--(Marketwired - November 06, 2017) - NeutriSci International Inc. (the "Company" or "NeutriSci") (TSX VENTURE: NU) (OTCQB: NRXCF) (FRANKFURT: 1N9), the innovator and pioneer behind neuenergy®, is pleased to announce that its partner in Japan and South Korea for Ambarii Corporation ("Ambarii") CBD products, Naturally Splendid USA ("Naturally Splendid"), expects final approval imminently from the Japanese government for distribution of CBD products in Japan. (5-0)

3 Marijuana Stocks To Watch On Friday

2017-11-04 accesswire
CORAL GABLES, FL / ACCESSWIRE / November 3, 2017 / The legal marijuana industry is projected to achieve a compound annual growth of 25% to hit $20 billion in the next 4 years. It's no surprise that the marijuana industry is one of the most dynamic and rapidly growing industries throughout the United States and Canada. With that being said, here are three active marijuana stocks to have on your watch-list on Friday. (24-0)

NetworkNewsWire Announces Publication on the Wide-Ranging Potential of Patented Technology for Improved Bioabsorption

2017-11-04 marketwired
NEW YORK, NY--(Marketwired - Nov 3, 2017) - NetworkNewsWire ("NNW"), a multifaceted financial news and publishing company, today announces the publication of an editorial featuring Lexaria Bioscience Corp. (CSE: LXX) (OTCQB: LXRP), a client of NNW that develops and out-licenses its proprietary technology for improved taste, rapidity, and delivery of bioactive compounds, including cannabinoids. (5-0)